Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H U Group Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was 円22.62.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円164.48.
During the past 12 months, the average EBIT per Share Growth Rate of H U Group Holdings was 83.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -40.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for H U Group Holdings's EBIT per Share or its related term are showing as below:
TSE:4544'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -62.6 Med: 5.2 Max: 51.1
Current: -40.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of H U Group Holdings was 51.10% per year. The lowest was -62.60% per year. And the median was 5.20% per year.
TSE:4544's 3-Year EBIT Growth Rate is ranked worse than 92.17% of 166
companies
in the Medical Diagnostics & Research industry
Industry Median: 13.1
vs TSE:4544: -40.80
H U Group Holdings (TSE:4544) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
H U Group Holdings EBIT per Share Related Terms
H U Group Holdings EBIT per Share Historical Data
* Premium members only.
The historical data trend for H U Group Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円164.48
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H U Group Holdings (TSE:4544) has a EBIT per Share of 円164.48 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on H U Group Holdings and its competitors. According to the industry distribution chart, H U Group Holdings ranks #153 out of 166 companies in the Medical Diagnostics & Research industry, placing it in the top 92.2%.
Is H U Group Holdings' EBIT per Share too high?
H U Group Holdings' current EBIT per Share is 円164.48. Based on the distribution chart, H U Group Holdings ranks #153 out of 166 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, H U Group Holdings has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' EBIT per Share compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, H U Group Holdings ranks #153 out of 166 companies for EBIT per Share. This places H U Group Holdings in the lower half of its industry. The industry median EBIT per Share is 13.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 13.10, based on 166 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on H U Group Holdings and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 13.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H U Group Holdings's current EBIT per Share is 円164.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (TSE:4544) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,776.53, compared to a current price of 円3,352.00 — trading 20.7% above its estimated fair value. The current EBIT per Share is 円164.48. H U Group Holdings' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For H U Group Holdings (TSE:4544), the current EBIT per Share is 円164.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H U Group Holdings (TSE:4544) Overvalued in 2026?
Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued.
The current stock price of 円3,352.00 is trading 20.7% above its estimated GF Value™ of 円2,776.53.
GuruFocus considers H U Group Holdings to be Modestly Overvalued.
Key valuation signals for TSE:4544:
EBIT per Share: 円164.48
GF Value™: 円2,776.53 vs. price of 円3,352.00 (20.7% above fair value)
No single metric tells the full story. See the TSE:4544 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
72GF Score
Get the complete analysis for TSE:4544
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4544 has been successfully added to your 
